{"id":"https://openalex.org/W4283388155","doi":"https://doi.org/10.1016/j.jsat.2022.108830","title":"Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes","display_name":"Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes","publication_year":2022,"publication_date":"2022-06-22","ids":{"openalex":"https://openalex.org/W4283388155","doi":"https://doi.org/10.1016/j.jsat.2022.108830","pmid":"https://pubmed.ncbi.nlm.nih.gov/35773113","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10012431"},"language":"en","primary_location":{"id":"doi:10.1016/j.jsat.2022.108830","doi":"https://doi.org/10.1016/j.jsat.2022.108830","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jsat.2022.108830","pdf_url":null,"source":{"id":"https://openalex.org/S82881359","display_name":"Journal of Substance Abuse Treatment","issn_l":"0740-5472","issn":["0740-5472","1873-6483"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","jufo-1","ki-jl-1","norway-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Journal of Substance Abuse Treatment","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jsat.2022.108830","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034186270","display_name":"Amanda M. Bunting","orcid":"https://orcid.org/0000-0002-2103-9655","observed_orcids":["https://orcid.org/0000-0002-2103-9655"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Amanda M. Bunting","raw_affiliation_strings":["Department of Population Health, NYU School of Medicine, New York, NY, United States of America. Electronic address: amanda.bunting@nyulangone.org","Department of Population Health, NYU School of Medicine, New York, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Population Health, NYU School of Medicine, New York, NY, United States of America. Electronic address: amanda.bunting@nyulangone.org","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Department of Population Health, NYU School of Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077801791","display_name":"Noa Krawczyk","orcid":"https://orcid.org/0000-0002-7396-3938","observed_orcids":["https://orcid.org/0000-0002-7396-3938"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noa Krawczyk","raw_affiliation_strings":["Department of Population Health, NYU School of Medicine, New York, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Population Health, NYU School of Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086344811","display_name":"Tse-Hwei J. Choo","orcid":"https://orcid.org/0000-0001-5068-9799","observed_orcids":["https://orcid.org/0000-0001-5068-9799"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tse-Hwei Choo","raw_affiliation_strings":["Department of Biostatistics, Mailman School of Public Health, Columbia University, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Mailman School of Public Health, Columbia University, United States of America","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079969867","display_name":"Martina Pavlicov\u00e1","orcid":"https://orcid.org/0000-0003-4400-4102","observed_orcids":["https://orcid.org/0000-0003-4400-4102"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martina Pavlicova","raw_affiliation_strings":["Department of Biostatistics, Mailman School of Public Health, Columbia University, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Mailman School of Public Health, Columbia University, United States of America","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033433488","display_name":"Jennifer McNeely","orcid":"https://orcid.org/0000-0003-4601-6940","observed_orcids":["https://orcid.org/0000-0003-4601-6940"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer McNeely","raw_affiliation_strings":["Department of Population Health, NYU School of Medicine, New York, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Population Health, NYU School of Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071630432","display_name":"Babak Tofighi","orcid":"https://orcid.org/0000-0001-7393-7564","observed_orcids":["https://orcid.org/0000-0001-7393-7564"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Babak Tofighi","raw_affiliation_strings":["Department of Population Health, NYU School of Medicine, New York, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Population Health, NYU School of Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071920736","display_name":"John Rotrosen","orcid":"https://orcid.org/0000-0002-0283-5576","observed_orcids":["https://orcid.org/0000-0002-0283-5576"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Rotrosen","raw_affiliation_strings":["Department of Psychiatry, Columbia University, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University, United States of America","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073707428","display_name":"Edward V. Nunes","orcid":"https://orcid.org/0000-0002-2055-3425","observed_orcids":["https://orcid.org/0000-0002-2055-3425"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Nunes","raw_affiliation_strings":["Department of Psychiatry, NYU School of Medicine, New York, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, NYU School of Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042175466","display_name":"Joshua D. Lee","orcid":"https://orcid.org/0000-0003-3161-2950","observed_orcids":["https://orcid.org/0000-0003-3161-2950","https://orcid.org/0000-0002-5907-0391"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua D. Lee","raw_affiliation_strings":["Department of Population Health, NYU School of Medicine, New York, NY, United States of America; Division of General Internal Medicine and Clinical Innovation, NYU School of Medicine, New York, NY, United States of America","Department of Population Health, NYU School of Medicine, New York, NY, United States of America","Division of General Internal Medicine and Clinical Innovation, NYU School of Medicine, New York, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Population Health, NYU School of Medicine, New York, NY, United States of America; Division of General Internal Medicine and Clinical Innovation, NYU School of Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Department of Population Health, NYU School of Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I57206974"]},{"raw_affiliation_string":"Division of General Internal Medicine and Clinical Innovation, NYU School of Medicine, New York, NY, United States of America","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5034186270"],"corresponding_institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"],"apc_list":{"value":3340,"currency":"USD","value_usd":3340},"apc_paid":null,"fwci":2.8691,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.90457688,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"143","issue":null,"first_page":"108830","last_page":"108830"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11860","display_name":"HIV, Drug Use, Sexual Risk","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polysubstance-use","display_name":"polydrug use","score":0.996999979019165},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/opioid-relapse","display_name":"opioid relapse","score":0.8320000171661377},{"id":"https://openalex.org/keywords/opioid-craving","display_name":"opioid craving","score":0.9980000257492065},{"id":"https://openalex.org/keywords/extended-release-naltrexone","display_name":"extended-release naltrexone","score":0.902999997138977},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cocaine-use","display_name":"cocaine use","score":0.7760000228881836},{"id":"https://openalex.org/keywords/sedative-use","display_name":"sedative use","score":0.9959999918937683},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.7620000243186951},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.4339999854564667}],"concepts":[{"id":"https://openalex.org/C121929971","wikidata":"https://www.wikidata.org/wiki/Q7227004","display_name":"Polysubstance dependence","level":3,"score":0.9807711839675903},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.8493223190307617},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7236194610595703},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.6076122522354126},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6021586656570435},{"id":"https://openalex.org/C2779541405","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Craving","level":3,"score":0.5743343830108643},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.5679178833961487},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5261585116386414},{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.5254753828048706},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3768582344055176},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.33148863911628723},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.2822217345237732},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2675735354423523},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.07131078839302063},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jsat.2022.108830","doi":"https://doi.org/10.1016/j.jsat.2022.108830","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jsat.2022.108830","pdf_url":null,"source":{"id":"https://openalex.org/S82881359","display_name":"Journal of Substance Abuse Treatment","issn_l":"0740-5472","issn":["0740-5472","1873-6483"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","jufo-1","ki-jl-1","norway-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Journal of Substance Abuse Treatment","raw_type":"journal-article"},{"id":"pmid:35773113","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35773113","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of substance abuse treatment","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:10012431","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10012431","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10012431/pdf/nihms-1865111.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Subst Abuse Treat","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.jsat.2022.108830","doi":"https://doi.org/10.1016/j.jsat.2022.108830","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jsat.2022.108830","pdf_url":null,"source":{"id":"https://openalex.org/S82881359","display_name":"Journal of Substance Abuse Treatment","issn_l":"0740-5472","issn":["0740-5472","1873-6483"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","jufo-1","ki-jl-1","norway-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Journal of Substance Abuse Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1086963315","display_name":null,"funder_award_id":"UG1/U10DA013714","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G114177176","display_name":"Florida Node Alliance of the Drug Abuse Clinic Trials Network","funder_award_id":"U10DA013720","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G138054407","display_name":null,"funder_award_id":"UG1/U10DA013714","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1451639521","display_name":"Clinical Trials Network: Greater New York Node","funder_award_id":"U10DA013035","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1548455081","display_name":null,"funder_award_id":"UG1/U10DA013034","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G1842581027","display_name":"NIDA Clinical Trials Network - New York Node","funder_award_id":"U10DA013046","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1880306645","display_name":null,"funder_award_id":"U10 DA013720","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G2021419551","display_name":null,"funder_award_id":"U10-DA013034","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2151805093","display_name":null,"funder_award_id":"UG1/U10DA013035","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2224778681","display_name":"Clinical Trials Network, Ohio Valley Node U10DA013732","funder_award_id":"U10DA013732","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2341182275","display_name":null,"funder_award_id":"U10 DA013714","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G2648674967","display_name":null,"funder_award_id":"UG1/ U10DA013035","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G2752743925","display_name":null,"funder_award_id":"HHSN271201500065C","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G3696061825","display_name":null,"funder_award_id":"K23DA042140","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G3700810839","display_name":"Development of a text messaging tool to support buprenorphine treatment in primary care","funder_award_id":"K23DA042140","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3839409028","display_name":null,"funder_award_id":"UG1/U10DA013732","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G3879315323","display_name":null,"funder_award_id":"UG1/U10DA015831","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G4059561276","display_name":null,"funder_award_id":"R25DA037190","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G4074371618","display_name":null,"funder_award_id":"U10DA013732","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G4390412455","display_name":null,"funder_award_id":"U10DA015833","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G4867824689","display_name":"The National Drug Abuse Treatment Clinical Trials Network","funder_award_id":"U10DA013045","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5112719437","display_name":"Clinical Trials Network: Pacific Northwest Node","funder_award_id":"U10DA013714","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5204689436","display_name":"Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative","funder_award_id":"UG1DA013034","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5727918891","display_name":"The National Drug Abuse Treatment Clinical Trials Network (U10)","funder_award_id":"U10DA015831","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6358071488","display_name":null,"funder_award_id":"UG1/U10DA015831","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G6415011113","display_name":"Clinical Trials Network: Southwest Node","funder_award_id":"U10DA015833","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6429698798","display_name":null,"funder_award_id":"HHSN271201500065C","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6752561216","display_name":null,"funder_award_id":"UG1/U10DA013034","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6827694873","display_name":null,"funder_award_id":"T32HS026120","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"},{"id":"https://openalex.org/G704638895","display_name":"Clinical Trials Network Mid-Atlantic Collaborative Group","funder_award_id":"5u10da013034-15","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7063556272","display_name":null,"funder_award_id":"UG1/U10DA013720","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7103278837","display_name":null,"funder_award_id":"U10DA013045","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G7569960938","display_name":null,"funder_award_id":"T32HS026120","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G7770300807","display_name":null,"funder_award_id":"U10DA013046","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G779219409","display_name":null,"funder_award_id":"HHSN271201200017C","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7904857782","display_name":null,"funder_award_id":"UG1/U10DA013720","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G854964702","display_name":null,"funder_award_id":"UG1/U10DA013732","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8721703235","display_name":null,"funder_award_id":"K01DA053435","funder_id":"https://openalex.org/F4320338410","funder_display_name":"National Drug Abuse Treatment Clinical Trials Network"},{"id":"https://openalex.org/G9000867860","display_name":"CTN New England Consortium Node","funder_award_id":"UG1DA015831","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000880887","display_name":"NIDA Clinical Trials Network: New York Node - Renewal-GY24","funder_award_id":"UG1DA013035","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000896336","display_name":"The Ohio Valley Node of the Clinical Trials Network","funder_award_id":"UG1DA013732","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000904551","display_name":"Collaborative Justice-Involved Research and Training Program on Substance Use and HIV at Brown University Health","funder_award_id":"R25DA037190","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000905216","display_name":"The Florida Node Alliance of the National Drug Abuse Clinical Trials Network","funder_award_id":"UG1DA013720","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000906086","display_name":"Training Program on HIV and Substance Use in the Criminal Justice System","funder_award_id":"T32DA037801","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000909821","display_name":"Clinical Trials Network: Pacific Northwest Node","funder_award_id":"UG1DA013714","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000915617","display_name":"Development of a novel polysubstance assessment tool for vulnerable subpopulations","funder_award_id":"K01DA053435","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320338410","display_name":"National Drug Abuse Treatment Clinical Trials Network","ror":null}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W2022774038","https://openalex.org/W2026622335","https://openalex.org/W2030762522","https://openalex.org/W2040942076","https://openalex.org/W2109443771","https://openalex.org/W2127569342","https://openalex.org/W2130544434","https://openalex.org/W2138547978","https://openalex.org/W2149717129","https://openalex.org/W2158920618","https://openalex.org/W2162471331","https://openalex.org/W2170697705","https://openalex.org/W2271565152","https://openalex.org/W2333643931","https://openalex.org/W2517652980","https://openalex.org/W2742469005","https://openalex.org/W2768214444","https://openalex.org/W2897850254","https://openalex.org/W2942772596","https://openalex.org/W2973129289","https://openalex.org/W2990459606","https://openalex.org/W3000666598","https://openalex.org/W3027206624","https://openalex.org/W3033306528","https://openalex.org/W3046248416","https://openalex.org/W3082063364","https://openalex.org/W3087096407","https://openalex.org/W3094289950","https://openalex.org/W3133038790","https://openalex.org/W3194984197","https://openalex.org/W3205115907","https://openalex.org/W4213367093","https://openalex.org/W6996968084"],"related_works":["https://openalex.org/W4284879430","https://openalex.org/W4310718211","https://openalex.org/W4385652410","https://openalex.org/W3027206624","https://openalex.org/W4376880054","https://openalex.org/W7203924377","https://openalex.org/W4408507858","https://openalex.org/W3082663102","https://openalex.org/W6958277516","https://openalex.org/W4388014892"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-06-25T00:00:00"}